Skip to main content
. 2015 Mar 19;33(8):811–831. doi: 10.1007/s40273-015-0268-9

Table 3.

Incidence studies on the costs of diabetes

References Country Time horizon Population Approach Results
[52] Canada 1992–2001 Incidence T2D pts from Saskatchewan Health’s administrative database in Canada Sum-all medical Highest total healthcare costs at year of diagnosis with CAN$7,343 ($7,635), then increased from a low of CANS$3,880 ($4,034) 3 years after diagnosis to CAN$4,441 ten years thereafter ($4,618)
[19] Colombia 32 years Hypothetical average Columbian T2D pt Sum-all medical Total lifetime costs (32-year period) of average diabetes pt, including direct and indirect costs, 57.565 million Colombian pesos ($54,351)
[21] Germany 1995–2003 Newly diagnosed T2D pts from randomly drawn practices across Germany Sum-all medical €1,288 ($1,635) for the first treatment year after diabetes diagnosis and increased to €3,845 ($4,880) in the 7th year
[73] USA 1997–1998 Women employed by nationwide operating company and hypothetical women above age 64 receiving Medicare RB/matching $282,973 incremental lifetime direct healthcare costs, using incidence-based, steady-state methodology

pt(s) patient(s), RB regression based, T2D type 2 diabetes